Article Text

PDF
Cats
The novel use of intravenous pimobendan and oral torasemide in a cat with congestive heart failure secondary to end-stage hypertrophic cardiomyopathy
  1. Jorge Prieto-Ramos,
  2. Katie McNaught and
  3. Anne T French
  1. Small Animal Hospital, University of Glasgow, Glasgow, UK
  1. Correspondence to Dr Jorge Prieto-Ramos, jprietoramos{at}hotmail.com

Abstract

A nine-year-old male neutered domestic short-haired cat presented with acute onset of dyspnoea and tachypnoea. The investigations performed including thoracic radiography and echocardiography led to a diagnosis of congestive heart failure secondary to end-stage hypertrophic cardiomyopathy. In addition to the standard treatment with intravenous diuretics, intravenous pimobendan was administered. No side effects or adverse reactions were noted after the administration of the drug. Complete resolution of the clinical signs was achieved. The patient was discharged from the hospital on oral medication with furosemide, pimobendan and clopidogrel. The furosemide was replaced two months later with torasemide due to refractory pleural effusion. This drug was well tolerated and resulted in marked clinical improvement. To the authors’ knowledge, this is the first report of the use of intravenous pimobendan and oral torasemide in a cat with congestive heart failure.

Statistics from Altmetric.com

  • Received November 17, 2015.
  • Revision received December 16, 2015.
  • Accepted December 20, 2015.
View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.